The DOI matches its Crossref record; 305 of the 305 references it cites were found in a registry or an index.
Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy
Open accessAbstract
Diabetic nephropathy (DN) is associated with an increased morbidity and mortality, resulting in elevated cost for public health systems. DN is the main cause of chronic kidney disease (CKD) and its incidence increases the number of patients that develop the end-stage renal disease (ESRD). There are growing epidemiological and preclinical evidence about the close relationship between inflammatory response and the occurrence and progression of DN. Several anti-inflammatory strategies targeting specific inflammatory mediators (cell adhesion molecules, chemokines and cytokines) and intracellular signaling pathways have shown beneficial effects in experimental models of DN, decreasing proteinuria and renal lesions. A number of inflammatory molecules have been shown useful to identify diabetic patients at high risk of developing renal complications. In this review, we focus on the key role of inflammation in the genesis and progression of DN, with a special interest in effector molecules and activated intracellular pathways leading to renal damage, as well as a comprehensive update of new therapeutic strategies targeting inflammation to prevent and/or retard renal injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–305 of 305
Zhang, Y., Wang, Y., Luo, M., Xu, F., Lu, Y., Zhou, X., Cui, W., & Miao, L. (2019) · Peptides · doi:10.1016/j.peptides.2019.04.005 · Cited by 68
Diabetes-Induced Activation of Canonical and Noncanonical Nuclear Factor-κB Pathways in Renal Cortex
Starkey, J. M., Haidacher, S. J., LeJeune, W. S., Zhang, X., Tieu, B. C., Choudhary, S., Brasier, A. R., Denner, L. A., & Tilton, R. G. (2006) · Diabetes · doi:10.2337/db05-1554 · Cited by 67
Li, H., Jiang, Y., Chang, T., Wei, J., Lin, M., Lin, C.-H., Chiang, F., Shih, S., Hung, C. S., Hua, C., et al. (2011) · Diabetes · doi:10.2337/db10-0607 · Cited by 67
Song, Y., Liu, W., Tang, K., Zang, J., Li, D., & Gao, H. (2020) · Journal of Diabetes Research · doi:10.1155/2020/9481720 · Cited by 67
Fujita, T., Ogihara, N., Kamura, Y., Satomura, A., Fuke, Y., Shimizu, C., Wada, Y., & Matsumoto, K. (2010) · Acta Diabetologica · doi:10.1007/s00592-010-0178-4 · Cited by 66
Targeting T helper 17 by mycophenolate mofetil attenuates diabetic nephropathy progression
Kim, S.-M., Lee, S. H., Lee, A., Kim, D.-J., Kim, Y., Kim, S., Jeong, K.-H., Lee, T., Ihm, C., Lim, S., et al. (2015) · Translational research · doi:10.1016/j.trsl.2015.04.013 · Cited by 65
Zheng, J., Yao, G., Cheng, Z., Wang, R., & Liu, Z. (2011) · Diabetologia · doi:10.1007/s00125-011-2391-2 · Cited by 65
Interleukin 17A Participates in Renal Inflammation Associated to Experimental and Human Hypertension
Orejudo, M., Rodrigues-Díez, R. R., Rodrigues‐Díez, R., García‐Redondo, A. B., Santos‐Sanchez, L., Rández‐Garbayo, J., Cannata‐Ortiz, P., Ramos, A. M., Ortíz, A., Selgas, R., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01015 · Cited by 65
Self-citationGremlin regulates renal inflammation via the vascular endothelial growth factor receptor 2 pathway
Lavoz, C., Alique, M., Rodrigues‐Díez, R., Pató, J., Kéri, G., Mezzano, S. A., Egido, J., & Ruiz‐Ortega, M. (2015) · The Journal of Pathology · doi:10.1002/path.4537 · Cited by 64
Self-citationMacrophages promote prosclerotic responses in cultured rat mesangial cells
Pawluczyk, I. Z. A., & Harris, K. P. G. (1997) · Journal of the American Society of Nephrology · doi:10.1681/asn.v8101525 · Cited by 64
CX3CL1/CX3CR1 Axis, as the Therapeutic Potential in Renal Diseases: Friend or Foe?
Zhuang, Q., Cheng, K., & Ming, Y. (2018) · Current Gene Therapy · doi:10.2174/1566523218666180214092536 · Cited by 64
Otsuka, Y., Kiyohara, C., Kashiwado, Y., Sawabe, T., Nagano, S., Kimoto, Y., Ayano, M., Mitoma, H., Akahoshi, M., Arinobu, Y., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196368 · Cited by 64
Li, H., Zhang, L., Wang, F., Shi, Y., Ren, Y., Liu, Q., Cao, Y., & Duan, H. (2011) · American Journal of Nephrology · doi:10.1159/000324694 · Cited by 61
Lopez‐Sanz, L., Bernal, S., Recio, C., Lázaro, I., Oguiza, A., Melgar, A., Jiménez-Castilla, L., Egido, J., & Gómez‐Guerrero, C. (2018) · Laboratory Investigation · doi:10.1038/s41374-018-0043-6 · Cited by 61
Self-citationGlucagon-Like Peptide 1 and Its Cleavage Products Are Renoprotective in Murine Diabetic Nephropathy
Moellmann, J., Klinkhammer, B. M., Onstein, J., Stöhr, R., Jankowski, V., Jankowski, J., Lebherz, C., Tacke, F., Marx, N., Boor, P., et al. (2018) · Diabetes · doi:10.2337/db17-1212 · Cited by 60
Gohda, T., Maruyama, S., Kamei, N., Yamaguchi, S., Shibata, T., Murakoshi, M., Horikoshi, S., Tomino, Y., Ohsawa, I., Gotoh, H., et al. (2017) · Scientific Reports · doi:10.1038/srep43520 · Cited by 58
Serum vascular adhesion protein-1 is increased in acute and chronic hyperglycemia
Li, H., Wei, J., Lin, M., Smith, D. J., Vainio, J., Lin, C.-H., Chiang, F., Shih, S., Huang, C.-H., Wu, M.-Y., et al. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.03.041 · Cited by 57
Evans, J., Collins, M., Jennings, C., van der Merwe, L., Söderström, I., Olsson, T., Levitt, N. S., Lambert, E. V., & Goedecke, J. H. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0463 · Cited by 57
Shang, J., Zhang, Y., Jiang, Y., Li, Z., Duan, Y., Wang, L., Xiao, J., & Zhao, Z. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.01.155 · Cited by 57
Fractalkine and Its Receptor, CX3CR1, Upregulation in Streptozotocin-Induced Diabetic Kidneys
Kikuchi, Y., Ikee, R., Hemmi, N., Hyodo, N., Saigusa, T., Namikoshi, T., Yamada, M., Suzuki, S., & Miura, S. (2004) · Nephron Experimental Nephrology · doi:10.1159/000077594 · Cited by 56
Radical scavenging effect of gliclazide in diabetic rats fed with a high cholesterol diet
Onozato, M. L., Tojo, A., Goto, A., & Fujita, T. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00470.x · Cited by 56
Suppressor of Cytokine Signaling-1 Peptidomimetic Limits Progression of Diabetic Nephropathy
Recio, C., Lázaro, I., Oguiza, A., Lopez‐Sanz, L., Bernal, S., Blanco, J., Egido, J., & Gómez‐Guerrero, C. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016020237 · Cited by 56
Self-citationJAK-STAT-dependent regulation of scavenger receptors in LPS-activated murine macrophages
Hashimoto, R., Kakigi, R., Miyamoto, Y., Nakamura, K., Itoh, S., Daida, H., Okada, T., & Katoh, Y. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.172940 · Cited by 56
Song, J., Zhang, H., Sun, Y., Guo, R., Zhong, D., Xu, R., & Song, M. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.08.002 · Cited by 55
Maile, L. A., Busby, W. H., Gollahon, K. A., Flowers, W. L., Garbacik, N., Garbacik, S. R., Stewart, K. R., Nichols, T. C., Bellinger, D. A., Patel, A., et al. (2014) · Endocrinology · doi:10.1210/en.2014-1318 · Cited by 54
Song, K., Park, J., Park, J. H., Natarajan, R. D., & Ha, H. (2013) · Diabetologia · doi:10.1007/s00125-013-2907-z · Cited by 54
Elevated Serum Level of Interleukin 17 in a Population With Prehypertension
Yao, W., Sun, Y., Wang, X., & Niu, K. (2015) · Journal of Clinical Hypertension · doi:10.1111/jch.12612 · Cited by 53
Zhou, X., Ji, Z., Haimbach, R. E., Zhu, W., Mayer‐Ezell, R., Garcia-Calvo, M. M., Smith, E., Price, O., Kan, Y., Zycband, E., et al. (2017) · Pharmacology Research & Perspectives · doi:10.1002/prp2.354 · Cited by 53
Jing, D., Bai, H., & Yin, S. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5131 · Cited by 53
Kaplan, M., Kerry, R., Aviram, M., & Hayek, T. (2008) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181879d98 · Cited by 52
Gale, J. D., Gilbert, S. A., Blumenthal, S. S., Elliott, T., Pérgola, P. E., Goteti, K., Scheele, W. H., & Huguet, C. (2018) · Kidney International Reports · doi:10.1016/j.ekir.2018.07.010 · Cited by 52
Yang, Z., Wang, H., Wang, Y.-I., Zhai, Z., Liu-Wei, W., Li, L., Zhang, C., & Tang, L. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00647 · Cited by 52
Wang, Y., Yu, B., Wang, L., Yang, M., Xia, Z., Wei, W., Zhang, F., & Yuan, X. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181248 · Cited by 51
Yin, W., Xu, S., Wang, Z., Liu, H., Peng, L., Fang, Q., Deng, T., Zhang, W., & Lou, J. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.11.076 · Cited by 51
Zhang, J., Zhao, X., Zhu, H., Wang, J., Ma, J., & Gu, M. (2019) · Medical Science Monitor · doi:10.12659/msm.915038 · Cited by 51
Serum IL-9, IL-17, and TGF-β levels in subjects with diabetic kidney disease (CURES-134)
Vasanthakumar, R., Mohan, V., Anand, G., Deepa, M., Babu, S., & Aravindhan, V. (2014) · Cytokine · doi:10.1016/j.cyto.2014.10.009 · Cited by 50
de Zeeuw, D., Renfurm, R. W., Bakris, G. L., Rossing, P. R., Perkovic, V., Hou, F. F., Nangaku, M., Sharma, K., Heerspink, H. J. L., García-Hernández, A., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30289-4 · Cited by 50
Shang, J., Wan, Q., Wang, X., Duan, Y., Wang, Z., Wei, X., Zhang, Y., Wang, H., Wang, R., & Yi, F. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.12.013 · Cited by 48
Islet Antigen-Specific Th17 Cells Can Induce TNF-α–Dependent Autoimmune Diabetes
Li, C.-R., Mueller, E. E., & Bradley, L. M. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301742 · Cited by 48
Tanaka, Y., Kume, S., Chin‒Kanasaki, M., Araki, H., Araki, S., Ugi, S., Sugaya, T., Uzu, T., & Maegawa, H. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.01.109 · Cited by 47
Renal p38 MAP kinase activity in experimental diabetes
Komers, R., Lindsley, J. N., Oyama, T., Cohen, D., & Anderson, S. (2007) · Laboratory Investigation · doi:10.1038/labinvest.3700549 · Cited by 46
Tubular overexpression of Gremlin in transgenic mice aggravates renal damage in diabetic nephropathy
Marchant, V. A., Droguett, A., Valderrama, G., Burgos, M. E., Carpio, D., Kerr, B., Ruiz‐Ortega, M., Egido, J., & Mezzano, S. (2015) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00023.2015 · Cited by 46
Self-citationAgere, S. A., Kim, E. Y., Akhtar, N., & Ahmed, S. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26388 · Cited by 46
Oguiza, A., Recio, C., Lázaro, I., Mallavia, B., Blanco, J., Egido, J., & Gómez‐Guerrero, C. (2015) · Diabetologia · doi:10.1007/s00125-015-3596-6 · Cited by 45
Self-citationNovel Biomarkers for the Progression of Diabetic Nephropathy: Soluble TNF Receptors
Gohda, T., & Tomino, Y. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0385-9 · Cited by 45
Huang, W. G., Gou, F., Long, Y., Li, Y., Feng, H., Zhang, Q., Gao, C., Chen, G., & Xu, Y. (2016) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0042-105641 · Cited by 43
Baharlou, R., Ahmadi-Vasmehjani, A., Davami, M. H., Faraji, F., Atashzar, M. R., Karimipour, F., Sadeghi, A., Asadi, M.-A., & Khoubyari, M. (2016) · Immunological Investigations · doi:10.1080/08820139.2016.1197243 · Cited by 43
GLP-1 receptor agonists in diabetic kidney disease: from the patient-side to the bench-side
Dieter, B. P., Alicic, R. Z., & Tuttle, K. R. (2018) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00211.2018 · Cited by 43
Increased urinary levels of CXCL5, CXCL8 and CXCL9 in patients with Type 2 diabetic nephropathy
Higurashi, M., Ohya, Y., Joh, K., Muraguchi, M., Nishimura, M., Terawaki, H., Yagui, K., Hashimoto, N., Saitō, Y., & Yamada, K. (2008) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2007.12.001 · Cited by 42
Lopes-Virella, M. F., Carter, R. E., Baker, N. L., Lachin, J. M., & Virella, G. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr454 · Cited by 42
Sueud, T., Hadi, N. R., Abdulameer, R., Jamil, D. A., & Al-Aubaidy, H. A. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.11.022 · Cited by 42
IL-17 in Renal Immunity and Autoimmunity
Biswas, P. S. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1801042 · Cited by 42
Yahya, M. J., Ismail, P., Nordin, N., Akim, A. M., Yusuf, W. S. M., Adam, N. L., & Yusoff, M. J. (2019) · International Journal of Chronic Diseases · doi:10.1155/2019/2053015 · Cited by 42
Novel Derivative of Bardoxolone Methyl Improves Safety for the Treatment of Diabetic Nephropathy
Huang, Z., Mou, Y., Xu, X., Zhao, D., Lai, Y., Xu, Y., Chen, C., Li, P., Peng, S., Tian, J., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00971 · Cited by 40
Yin, D., Luo, J., Zhao, Z., Liao, Y., & Li, Y. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.8776 · Cited by 40
Hernández, C., Bogdanov, P. M., Gómez‐Guerrero, C., Sampedro, J., Solà-Adell, C., Espejo, C., García‐Ramírez, M., Priéto, I., Egido, J., & Simó, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153615 · Cited by 40
Self-citationFcγ Receptor Deficiency Attenuates Diabetic Nephropathy
López-Parra, V., Mallavia, B., López‐Franco, Ó., Ortiz-Muñoz, G., Oguiza, A., Recio, C., Blanco, J., Nimmerjahn, F., Egido, J., & Gómez‐Guerrero, C. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011080822 · Cited by 39
Self-citationSadi, G., Şahin, G., & Bostancı, A. (2018) · Medicina · doi:10.3390/medicina55010003 · Cited by 39
Okoń, K., & Stachura, J. (2007) · PubMed · Cited by 39
VEGFR2 Blockade Improves Renal Damage in an Experimental Model of Type 2 Diabetic Nephropathy
Lavoz, C., Rodrigues-Díez, R. R., Plaza, A., Carpio, D., Egido, J., Ruiz‐Ortega, M., & Mezzano, S. A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020302 · Cited by 38
Self-citationHerrera, M., Söderberg, M. P., Sabirsh, A., Valastro, B., Mölne, J., Santamaría, B., Valverde, Á. M., Guionaud, S., Heasman, S. C., Bigley, A. L., et al. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00179.2016 · Cited by 35
Srinivasan, M., Meadows, M. L., & Maxwell, L. (2018) · Biochemistry Research International · doi:10.1155/2018/7463796 · Cited by 35
Function of NLRP3 in the Pathogenesis and Development of Diabetic Nephropathy
Fu, Y., Wu, N., & Zhao, D. (2017) · Medical Science Monitor · doi:10.12659/msm.903269 · Cited by 34
Suppressor of Cytokine Signaling-1 Ameliorates Expression of MCP-1 in Diabetic Nephropathy
Shi, Y.-H., Du, C.-Y., Zhang, Y.-L., Ren, Y.-Z., Hao, J., Zhao, S., Yao, F., & Duan, H. (2010) · American Journal of Nephrology · doi:10.1159/000286559 · Cited by 33
Wang, L., Zhang, L., Yu, Y., Wang, Y., & Niu, N. (2008) · Renal Failure · doi:10.1080/08860220802272563 · Cited by 33
Nuclear DAMP complex-mediated RAGE-dependent macrophage cell death
Chen, R., Fu, S., Fan, X., Lotze, M. T., Zeh, H. J., Tang, D., & Kang, R. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.01.159 · Cited by 32
Suppressor of cytokine signaling (SOCS) 2 attenuates renal lesions in rats with diabetic nephropathy
Zhou, Y., Lv, C., Wu, C., Chen, F., Shao, Y., & Wang, Q. (2014) · Acta Histochemica · doi:10.1016/j.acthis.2014.04.002 · Cited by 32
Siddiqi, F. S., Chen, L.-H., Advani, S. L., Thai, K., Batchu, S. N., Alghamdi, T. A., White, K., Sood, M. M., Gibson, I. W., Connelly, K. A., et al. (2014) · Endocrinology · doi:10.1210/en.2014-1650 · Cited by 32
Liu, S., Chen, J., & Li, Y. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12828 · Cited by 32
Márquez‐Expósito, L., Lavoz, C., Rodrigues-Díez, R. R., Rayego‐Mateos, S., Orejudo, M., Cantero‐Navarro, E., Ortíz, A., Egido, J., Selgas, R., Mezzano, S. A., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01195 · Cited by 31
Self-citationKawamoto, R., Ninomiya, D., Kikuchi, A., Akase, T., Kasai, Y., Kusunoki, T., Ohtsuka, N., & Kumagi, T. (2019) · International Urology and Nephrology · doi:10.1007/s11255-018-02065-2 · Cited by 31
Kang, Z., Zeng, J., Zhang, T., Lin, S., Gao, J., Jiang, C., Fan, R., & Yin, D. (2019) · Cell Biology International · doi:10.1002/cbin.11184 · Cited by 30
Soluble Fn14 Is Detected and Elevated in Mouse and Human Kidney Disease
Sharif, M., Campanholle, G., Nagiec, E. E., Wang, J., Syed, J., O’Neil, S. P., Zhan, Y., Brenneman, K. A., Homer, B., Neubert, H., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155368 · Cited by 29
Gremlin and renal diseases: ready to jump the fence to clinical utility?
Mezzano, S. A., Droguett, A., Lavoz, C., Krall, P. M., Egido, J., & Ruiz‐Ortega, M. (2017) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfx194 · Cited by 29
Self-citationWang, R., Chen, T., Wang, C., Zhang, Z., Wang, X. M., Li, Q., Lee, V. W., Wang, Y. M., Zheng, G., Alexander, S. I., et al. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy385 · Cited by 29
Marques, C., Gonçalves, A., Pereira, P. M. R., Almeida, D., Martins, B. D., Ribeiro, C., Reis, F., & Fernandes, R. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116738 · Cited by 29
Liu, J., Zhao, Z., Willcox, M. D. P., Xu, B., & Shi, B. (2010) · Journal of Immunoassay and Immunochemistry · doi:10.1080/15321819.2010.524860 · Cited by 27
Amelioration of experimentally induced diabetic nephropathy and renal damage by nilotinib
Elsherbiny, N. M., El‐Sherbiny, M., & Said, E. (2015) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-015-0428-6 · Cited by 26
Tuttle, K. R., McGill, J. B., Bastyr, E. J., Poi, K. K., Shahri, N., & Anderson, P. W. (2015) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.11.024 · Cited by 26
Leptin and NGF in saliva of patients with diabetes mellitus type 2: A pilot study
Tvarijonaviciute, A., Castillo-Felipe, C., Cerón, J. M. C., Martínez-Subiela, S., Tecles, F., & López‐Jornet, P. (2017) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12587 · Cited by 26
Ruboxistaurin attenuates diabetic nephropathy via modulation of TGF-β1/Smad and GRAP pathways
Alonazi, A. S., Al-Rasheed, N. M., Attia, H., Al‐Rasheed, N. M., Ahmed, M., Alamin, M. A., & Poizat, C. I. (2016) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12504 · Cited by 25
Marwaha, A., Panagiotopoulos, C., Biggs, C. M., Staiger, S., Bel, K. L. D., Hirschfeld, A. F., Priatel, J. J., Turvey, S. E., & Tan, R. (2017) · Genes and Immunity · doi:10.1038/gene.2016.44 · Cited by 25
Role of chemokines in proteinuric kidney disorders
Moreno, J. A., Moreno, S., Rubio‐Navarro, A., Gómez‐Guerrero, C., Ortíz, A., & Egido, J. (2014) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2014.3 · Cited by 24
Self-citationParadoxical Role of IL-17 in Progression of Diabetic Nephropathy
Galvan, D. L., & Danesh, F. R. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015070813 · Cited by 24
Lopes-Virella, M. F., Hunt, K. J., Baker, N. L., & Virella, G. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.01.012 · Cited by 24
Cui, Z., Lu, X., Xiao, K., Chen, Y., & Li, H. (2019) · Current Medical Science · doi:10.1007/s11596-019-2027-1 · Cited by 24
Interleukin-20 targets podocytes and is upregulated in experimental murine diabetic nephropathy
Hsu, Y., Li, H.-H., Sung, J., Chen, W., Hou, Y., Weng, Y.-H., Lai, W.-T., Wu, C., & Chang, M. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.169 · Cited by 23
Targeting Nrf2 in Protection Against Renal Disease
Guerrero‐Hue, M., Farré‐Alins, V., Palomino‐Antolín, A., Parada, E., Rubio‐Navarro, A., Egido, J., Egea, J., & Moreno, J. A. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666170511120814 · Cited by 23
Self-citationReversing CXCL10 Deficiency Ameliorates Kidney Disease in Diabetic Mice
Zhang, Y., Thai, K., Kepecs, D. M., Winer, D. A., & Gilbert, R. E. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.08.017 · Cited by 23
Wang, J., Hu, L., Chen, Y., Fu, T., Jiang, T., Jiang, A., & You, X. (2018) · Endocrine · doi:10.1007/s12020-018-1721-2 · Cited by 22
Abdelrahman, A. M., Suleimani, Y. M. A., Shalaby, A., Ashique, M., Manoj, P., & Ali, B. H. (2019) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-019-01655-w · Cited by 22
Wang, Z.-B., Zhang, S., Li, Y., Wang, R., Tong, L., Wang, Y., Liu, W., Su, D., Tu, Y., Zhang, L., et al. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2016.172 · Cited by 21
White, P. C., Adhikari, S., Grishman, E. K., & Sumpter, K. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12634 · Cited by 21
Wang, G., Lai, F. M., Chow, K., Kwan, B. C., Pang, W., Luk, C. C., Leung, C., Li, P. K., & Szeto, C. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2654 · Cited by 19
Macrophage foam cell formation is augmented in serum from patients with diabetic angiopathy
Cui, X., Kushiyama, A., Yoneda, M., Nakatsu, Y., Guo, Y., Zhang, J., Ono, H., Kanna, M., Sakoda, H., Ono, H., et al. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.10.011 · Cited by 19
Shen, Z., Chen, Q., Ying, H., Ma, Z., Bi, X., Li, X., Wang, M., Jin, C., Lai, D., Zhao, Y., et al. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.8239 · Cited by 19
Chen, L., Liu, X., Pan, Z., Liu, S., Han, H., Zhao, C., & Tang, X. (2017) · Chemosphere · doi:10.1016/j.chemosphere.2017.11.120 · Cited by 17
Tissue-Specific Induction of E-Selectin in Glomeruli Is Augmented following Diabetes mellitus
Narumi, S., Onozato, M. L., Tojo, A., Sakamoto, S., & Tamatani, T. (2001) · The Nephron journals/Nephron journals · doi:10.1159/000046063 · Cited by 15
Davis, H., Briscoe, V. J., Dumbadze, S., & Davis, S. N. (2019) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2019.1592156 · Cited by 15
Chymase inhibition retards albuminuria in type 2 diabetes
Bivona, B. J., Takai, S., Seth, D. M., Satou, R., & Harrison‐Bernard, L. M. (2019) · Physiological Reports · doi:10.14814/phy2.14302 · Cited by 15
Liu, L., He, D., Fang, L., & Yan, X. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0922-2 · Cited by 13
Mayer, C., Bergholdt, R., Cucak, H., Rolin, B., Sams, A. G., & Rosendahl, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131306 · Cited by 10
Utsumi, K., Yasuda, F., Watanabe, Y., et al. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.09.024 · Cited by 7
Wang, Y., Wei, Q., Liu, Q., Li, Z., Zhou, L., ZOU, F., Yuan, Y., & Sun, Z. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1703 · Cited by 6
Liu, W., Yu, J., Yan, Q., Wang, L., Li, N., & Xiong, W. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6449 · Cited by 3
Cited by
Targeting inflammation to treat diabetic kidney disease: the road to 2030
Rayego-Mateos, S., Rodrigues-Diez, R. R., Fernandez-Fernandez, B., Mora-Fernández, C., Marchant, V., Donate-Correa, J., Navarro-González, J. F., Ortiz, A., & Ruiz-Ortega, M. (2023) · Kidney International · doi:10.1016/j.kint.2022.10.030 · Cited by 366
Self-citationZhao, C., Pu, Z., Gao, J., Liu, C., Xing, J., Lang, W., Chen, J., Yuan, C., & Zhou, C. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c05595 · Cited by 26
Gao, R.-H., Liu, B., Yang, Y., Ran, R., Zhou, Y., & Liu, S.-M. (2023) · Diabetes, Metabolic Syndrome and Obesity · doi:10.2147/dmso.s409410 · Cited by 17
Zhu, H.-M., Liu, N., Sun, D.-X., & Luo, L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1202298 · Cited by 12
“There is a growing body of research that points to oxidative stress and inflammation as the primary contributors to the development of DN (3, 42).”
Background
Metadata
- Authors
- Rayego-Mateos, S., Morgado-Pascual, J. L., Opazo-Ríos, L., Guerrero-Hue, M., García-Caballero, C., Vázquez-Carballo, C., Mas, S., Sanz, A. B., Herencia, C., Mezzano, S., Gómez-Guerrero, C., Moreno, J. A., & Egido, J.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-05-27
- Volume
- 21
- Issue
- 11
- Pages
- 3798
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3032465091
- Cited by
- 334
- References
- 305
- FWCI
- 19.34
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.